zs-hematology-MM01

Published: 1 April 2022| Version 1 | DOI: 10.17632/636vgmk272.1
Contributors:
Yue Wang,

Description

The data included whole-exome sequencing data of 49 newly diagnosed DS stage III MM patients who received standard first-line therapy and did not undergo autologous stem cell transplantation, 7 patients with relapsed or refractory MM, and 7 patients with newly diagnosed monoclonal gammopathy of unknown significance between July 2017 and October 2019 at the department of hematology, Zhongshan hospital Fudan University.

Files

Institutions

Zhongshan Hospital Fudan University

Categories

High-Throughput Sequencing

Licence